AEGON Announces the Issuance of EUR 500 Million in Senior Unsecured Notes, due July 18, 2017

AEGON Announces the Issuance of EUR 500 Million in Senior Unsecured Notes, due
                                July 18, 2017

  PR Newswire

  THE HAGUE, The Netherlands, July 16, 2012

THE HAGUE, The Netherlands, July 16, 2012 /PRNewswire/ --

Not for distribution in the USA

The notes were issued under AEGON's USD 6 billion debt issuance program at a
price of 99.712%, and will carry a coupon of 3.00%. The transaction is
expected to close on July 18, 2012.

Net proceeds from this issuance will be used for general corporate purposes
and the redemption of short-term debt. Copies of documentation relating to
this offering are available on AEGON's corporate website http://www.aegon.com
.

^[ ^The Notes have not been and will not be registered under the United States
Securities Act of 1933 as amended (the 'Securities Act') and are subject to
certain ^United States ^tax law requirements. Subject to certain exceptions,
the Notes may not be offered, sold or delivered, directly or indirectly, in
the ^United States ^, or to or for the account or benefit of ^US ^. persons
^(as such terms are defined in Regulation S under the Securities Act). For a
further description of restrictions on offers, sales, resales and deliveries
of Notes, see 'Subscription and ^Sale ^' in the Base Prospectus. ^]

About AEGON

As an international life insurance, pensions and asset management company
based in The Hague, AEGON has businesses in over twenty markets in the
Americas, Europe and Asia. AEGON companies employ over 25,000 people and have
nearly 47 million customers across the globe.

                                               Full year
    Key figures - EUR              Q1 2012          2011

    Underlying earnings before
    tax                        425 million   1.5 billion
    New life sales             445 million   1.8 billion
                                      11.0
    Gross deposits                 billion    32 billion
    Revenue-generating
    investments
    (end of period)            437 billion   424 billion

Cautionary note regarding non-GAAP measures

This document includes a non-GAAP financial measure: underlying earnings
before tax. The reconciliation of underlying earnings before tax to the most
comparable IFRS measure is provided in Note 3 "Segment information" of AEGON's
Condensed consolidated interim financial statements.

Forward-looking statements

The statements contained in this document that are not historical facts are
forward-looking statements as defined in the US Private Securities Litigation
Reform Act of 1995. The following are words that identify such forward-looking
statements: aim, believe, estimate, target, intend, may, expect, anticipate,
predict, project, counting on, plan, continue, want, forecast, goal, should,
would, is confident, will, and similar expressions as they relate to AEGON.
These statements are not guarantees of future performance and involve risks,
uncertainties and assumptions that are difficult to predict. AEGON undertakes
no obligation to publicly update or revise any forward-looking statements.
Readers are cautioned not to place undue reliance on these forward-looking
statements, which merely reflect company expectations at the time of writing.
Actual results may differ materially from expectations conveyed in
forward-looking statements due to changes caused by various risks and
uncertainties. Such risks and uncertainties include but are not limited to the
following:

  * Changes in general economic conditions, particularly in the United States,
    the Netherlands and the United Kingdom;
  * Changes in the performance of financial markets, including emerging
    markets, such as with regard to:
  * The frequency and severity of defaults by issuers in AEGON's fixed income
    investment portfolios; and
  * The effects of corporate bankruptcies and/or accounting restatements on
    the financial markets and the resulting decline in the value of equity and
    debt securities AEGON holds;
  * The effects of declining creditworthiness of certain private sector
    securities and the resulting decline in the value of sovereign exposure
    that AEGON holds;
  * Changes in the performance of AEGON's investment portfolio and decline in
    ratings of the company's  counterparties;
  * Consequences of a potential (partial) break-up of the euro;
  * The frequency and severity of insured loss events;
  * Changes affecting mortality, morbidity, persistence and other factors that
    may impact the profitability of AEGON's insurance products;
  * Reinsurers to whom AEGON has ceded significant underwriting risks may fail
    to meet their obligations;
  * Changes affecting interest rate levels and continuing low or rapidly
    changing interest rate levels; changes affecting currency exchange rates,
    in particular the EUR/USD and EUR/GBP exchange rates;
  * Changes in the availability of, and costs associated with, liquidity
    sources such as bank and capital markets funding, as well as conditions in
    the credit markets in general such as changes in borrower and counterparty
    creditworthiness;
  * Increasing levels of competition in the United States, the Netherlands,
    the United Kingdom and emerging markets;
  * Changes in laws and regulations, particularly those affecting AEGON's
    operations, ability to hire and retain key personnel, the products the
    company sells, and the attractiveness of certain products to its
    consumers;
  * Changes in the policies of central banks and/or governments,;
  * Regulatory changes relating to the insurance industry in the jurisdictions
    in which AEGON operates;
  * Changes in customer behavior and public opinion in general related to,
    among other things, the type of products also AEGON sells, including
    legal, regulatory or commercial necessity to meet changing customer
    expectations;
  * Acts of God, acts of terrorism, acts of war and pandemics;
  * Lowering of one or more of AEGON's debt ratings issued by recognized
    rating organizations and the adverse impact such action may have on the
    company's ability to raise capital and on its liquidity and financial
    condition;
  * Lowering of one or more of insurer financial strength ratings of AEGON's
    insurance subsidiaries and the adverse impact such action may have on the
    premium writings, policy retention, profitability of its insurance
    subsidiaries and liquidity;
  * The effect of the European Union's Solvency II requirements and other
    regulations in other jurisdictions affecting the capital AEGON is required
    to maintain;
  * Litigation or regulatory action that could require AEGON to pay
    significant damages or change the way the company does business;
  * As AEGON's operations support complex transactions and are highly
    dependent on the proper functioning of information technology, a computer
    system failure or security breach may disrupt the company's business,
    damage its reputation and adversely affect its results of operations,
    financial condition and cash flows;
  * Customer responsiveness to both new products and distribution channels;
  * Competitive, legal, regulatory, or tax changes that affect profitability,
    the distribution cost of or demand for AEGON's products;
  * Changes in accounting regulations and policies may affect AEGON's reported
    results and shareholder's equity;
  * The impact of acquisitions and divestitures, restructurings, product
    withdrawals and other unusual items, including AEGON's ability to
    integrate acquisitions and to obtain the anticipated results and synergies
    from acquisitions;
  * Catastrophic events, either manmade or by nature, could result in material
    losses and significantly interrupt AEGON's business; and
  * AEGON's failure to achieve anticipated levels of earnings or operational
    efficiencies as well as other cost saving initiatives.

Further details of potential risks and uncertainties affecting the company are
described in the company's filings with NYSE Euronext Amsterdam and the US
Securities and Exchange Commission, including the Annual Report. These
forward-looking statements speak only as of the date of this document. Except
as required by any applicable law or regulation, the company expressly
disclaims any obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements contained herein to reflect any
change in the company's expectations with regard thereto or any change in
events, conditions or circumstances on which any such statement is based.

Contact information Media Relations: Greg Tucker +31-(0)70-344-8956
gcc-ir@aegon.com Investor Relations: Willem van den Berg +31-(0)70-344-8305
ir@aegon.com

http://www.aegon.com

 

PRN NLD